Rocket Lab SEC Filings

This 424B3 prospectus supplement updates the May 4, 2022 prospectus with the quarterly report on Form 10-Q filed August 11, 2022. Key facts include revenue of $55.5 million for Q2 2022, net loss of $37.4 million, and backlog of $531.4 million. Relevance to investors is the provision of updated financial position and results for the emerging growth company.

This 424B3 filing supplements the May 2022 prospectus with the Form 10-Q for quarter ended June 30, 2022. Key facts include revenue rising to $55.5M (up 392% YoY) from acquisitions and launches, net loss of $37.4M, cash at $542.5M, and 468M shares outstanding. It is relevant to investors as it discloses updated financials, risks, and forward-looking statements for RKLB.

Rocket Lab reported record Q2 2022 revenue of $55.5 million, representing 392% year-over-year growth. The company provided Q3 2022 revenue guidance of $60 million to $63 million and highlighted significant operational progress in both launch services and space systems.

Quarterly Report - Q2 2022

Rocket Lab reported Q2 revenue of $55M, up 392% YoY, driven by Space Systems growth and higher launch cadence. Gross margin declined to 9% from 22% YoY amid acquisition costs and stock comp. H1 operating cash flow was -$65M with cash at $543M; backlog reached $531M.

Alexander R. Slusky, a Director at Rocket Lab USA, Inc., acquired 38,090 restricted stock units (RSUs) on June 23, 2022, at $0.00 per share. This represents routine equity compensation under the Non-Employee Director Compensation Policy. The signal is neutral, as it is standard director pay rather than discretionary buying.

This 424B3 prospectus supplement updates the May 4 2022 prospectus with the June 27 2022 8-K on the June 23 2022 annual meeting. Key facts include election of three Class I directors and ratification of Deloitte as auditor for fiscal 2022. Relevance to investors is limited to standard governance confirmation with no financial or operational changes disclosed.

This 424B3 prospectus supplement updates the May 4, 2022 prospectus with the June 27, 2022 Form 8-K detailing the June 23, 2022 annual stockholder meeting. Key facts include election of three Class I directors and ratification of Deloitte & Touche LLP as auditor for fiscal 2022. It is relevant to investors as a standard corporate governance disclosure with no new financial or operational changes.

This 424B3 prospectus supplement updates the May 27, 2022 prospectus with the June 27, 2022 Form 8-K. The 8-K reports outcomes from the June 23, 2022 annual meeting where stockholders elected three Class I directors and ratified Deloitte & Touche LLP as auditor for fiscal 2022. It is relevant to investors as routine governance disclosure with no new financial or operational data.

Rocket Lab held its 2022 Annual Stockholders' Meeting on June 23, 2022, with 350M shares represented. Stockholders elected Jon Olson, Merline Saintil, and Alex Slusky as Class I directors for three-year terms. They ratified Deloitte & Touche LLP as independent auditors for FY 2022.

David J. Cowan, Director at Rocket Lab USA, acquired 38,090 shares of common stock via restricted stock units (RSUs) on June 23, 2022, at $0.00 under the Non-Employee Director Compensation Policy. Post-transaction, he directly owns 294,310 shares. This routine grant is neutral, reflecting standard director pay rather than discretionary buying.